This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Brigitte M Richard: Innovator in Vascular Endothelial Cell Growth Factor Treatments
Introduction
Brigitte M Richard is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biomedical research, particularly in the development of treatments utilizing variants of vascular endothelial cell growth factor (VEGF). His innovative work has the potential to enhance therapeutic effects in various medical applications.
Latest Patents
Brigitte M Richard holds 1 patent for his invention titled "Methods of treatment utilizing variants of vascular endothelial cell growth factor." This patent describes VEGF variants that have structural alterations in the C-terminus heparin binding domain. These variants exhibit reduced clearance rates for systemic administration at lower doses compared to native VEGF, providing longer availability for therapeutic effects.
Career Highlights
Richard is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking research and development in the field of vascular biology.
Collaborations
Throughout his career, Richard has collaborated with esteemed colleagues, including Thomas F Zioncheck and Geralyn G DeGuzman. These collaborations have fostered a productive environment for innovation and advancement in medical treatments.
Conclusion
Brigitte M Richard's contributions to the field of vascular endothelial cell growth factor treatments exemplify the impact of innovative research in medicine. His work continues to pave the way for new therapeutic options that can improve patient outcomes.